Physical Activity and Dementia Risk: Evidence from a Meta-Analysis and the Framingham Cohort

How serious is the dementia threat?

Alzheimer's disease and other forms of dementia rank seventh among leading causes of death globally. According to WHO projections, the number of people with dementia will reach 139 million by 2050 — driven primarily by population aging. No pharmacological treatment capable of halting progression exists today: approved drugs (cholinesterase inhibitors, lecanemab) provide modest symptomatic or disease-modifying effects.

Against this backdrop, modifiable risk factors — lifestyle, physical activity, diet, and social connections — take on particular importance. The Lancet Commission (2024) estimates that up to 45% of dementia cases are potentially preventable through intervention on known behavioral and biomedical risk factors.

What does the 2025 meta-analysis show for Alzheimer's disease?

Jiang and colleagues published in Journal of Neurology (2025) a dose-response meta-analysis based on 29 prospective cohort studies with a total sample of 1,453,561 participants, of whom 68,497 were diagnosed with Alzheimer's disease.

Key results:

• High vs. low physical activity: HR=0.74 (95% CI: 0.67-0.83) — a 26% reduction in Alzheimer's risk
• Dose-response: each 10 MET-h/week increase in physical load is associated with a 15% reduction in risk
• Dose-response curve is non-linear: the greatest benefit comes from transitioning from sedentary to moderately active

MET-h/week (metabolic equivalent × hours per week) is the standard unit for quantifying physical load. Brisk walking (3.5 MET) for 30 minutes per day gives 3.5 × 0.5 h × 7 days ≈ 12.3 MET-h/week — corresponding to slightly more than one dose-response step in the analysis.

What does the Framingham cohort add?

Marino, Lyu, Li and colleagues published in JAMA Network Open (2025) an analysis of the Framingham Heart Study cohort — one of the oldest prospective cohorts in the US, followed since 1948. The study included more than 4,300 participants (offspring of the original cohort), free of dementia at enrollment.

The key strength of the study is the separation of physical activity across three life periods:

• Early adulthood: no statistically significant association found (HR=1.00; 95% CI: 0.53-2.26; p=0.81)
• Midlife (ages 45-64): high physical activity index reduced dementia risk by 28% (HR=0.72; 95% CI: 0.54-0.94; p=0.02)
• Late life (ages 65-88): 37% reduction in dementia risk (HR=0.63; 95% CI: 0.45-0.87; p=0.005)

The absence of an association in early adulthood is not proof that early activity is useless. The authors note the limited sample size for that group (n=1,526) and insufficient statistical power for the early period.

What mechanisms explain the neuroprotective effect?

Observational data cannot establish mechanism, but experimental research points to several pathways:

• BDNF and neurogenesis: physical exercise increases brain-derived neurotrophic factor (BDNF) and stimulates hippocampal neurogenesis — a structure critical for forming new memories and one that atrophies in Alzheimer's disease.
• Cerebral vascular health: aerobic exercise reduces the risk of small strokes, chronic cerebral ischemia, and atherosclerosis of cerebral vessels — established risk factors for mixed dementia.
• Reduced neuroinflammation: regular physical activity is associated with suppression of pro-inflammatory cytokines (IL-6, TNF-alpha) and activation of anti-inflammatory pathways, which may slow neurodegeneration.
• Glymphatic system: physical activity improves sleep quality, which in turn activates the glymphatic system — the brain's mechanism for clearing beta-amyloid and tau protein.
• Cardiometabolic risk factors: obesity, hypertension, and type 2 diabetes are each independent dementia risk factors. Physical activity reduces the severity of all three.

Limitations of the evidence base

All listed data are observational. Key limitations:

• Residual confounding: physically active people on average lead healthier lifestyles overall (better diet, less smoking, higher socioeconomic status).
• Reverse causality: the onset of declining physical activity may be an early sign of preclinical dementia rather than its consequence.
• Differences in measuring activity across studies (accelerometers vs. self-report) create substantial heterogeneity.

Randomized controlled trials with dementia as the primary outcome (rather than surrogate cognitive measures) are almost nonexistent — the scale and follow-up duration make them practically impossible. Observational data from multiple independent cohorts therefore remain the basis for decision-making.